The FDA's Response to AI Medical Innovation

The Good Bot: Artificial Intelligence, Health Care, and the Law
25/06/2024 16 min Temporada 1 Episodio 2
The FDA's Response to AI Medical Innovation

Listen "The FDA's Response to AI Medical Innovation"

Descargar episodio Ver en sitio original

Episode Synopsis

Join Troutman Pepper Partner Brett Mason for a podcast series analyzing the intersection of artificial intelligence (AI), health care, and the law.In this installment, Brett is joined by Partner Judy O'Grady and Associate Kyle Dolinsky to discuss the FDA's approach to regulating AI in health care. Topics include AI's current and potential applications in medical devices and drug development, the FDA's proactive stance on AI innovation, and evolving regulatory frameworks. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More episodes of the podcast The Good Bot: Artificial Intelligence, Health Care, and the Law

AI Underwriting Uncovered: Risks, Data, and Liability in Insurance 20/11/2025
The IP Future: Intellectual Property Challenges in AI Health Care Contracts 24/10/2025
State AGs' Continued Focus on Enforcement – With or Without AI Legislation 16/09/2025
Evolving AI Legislation: Federal Policies, Task Forces, and Proposed Laws 20/05/2025
AI in Employment: Navigating the Legal Landscape with Lessons from I, Robot - The Good Bot 22/04/2025
DOJ Addresses AI in Corporate Compliance Programs 25/03/2025
Colorado AI Act 20/02/2025
The Growing Role of State AGs in AI Regulatory & Enforcement Issues 21/01/2025
AI and Pharmacovigilance Under the FDA's New Emerging Drug Safety Technology Program 11/12/2024
Harnessing Generative AI: Innovations and Best Practices 19/11/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA